Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

NCT06132828 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: DR30206

Sponsor

Zhejiang Doer Biologics Co., Ltd.